Breast Implant Rupture
Breast implant rupture means the outer shell of the implant has developed a tear or hole. What happens next depends entirely on what the implant contains. A saline implant deflates visibly over hours or days, so rupture is obvious and needs no imaging to diagnose. A silicone implant usually gives no sign at all—the cohesive gel inside modern implants stays largely within the surrounding capsule, so the breast looks and feels unchanged. This is called silent rupture, and it is common enough that it cannot be detected by examination. Rupture is not a medical emergency and contained silicone has not been shown to cause systemic illness, but implants have a finite lifespan and rupture rates rise steadily with age.
What is it?
Every breast implant consists of a silicone outer shell containing either silicone gel or sterile saline. Rupture means that shell has developed a tear, hole, or crack.
After any implant is placed, the body forms a layer of fibrous tissue around it called the capsule. This is a normal response to any foreign material and is not a complication in itself. Its relevance to rupture is considerable: the capsule acts as a second containing layer, and whether gel stays inside it or escapes beyond it determines how serious a rupture is and how it is managed.
This produces the key distinction in silicone rupture.
Intracapsular rupture, which accounts for the great majority, means the shell has failed but the gel remains contained within the surrounding capsule. The gel sits where it always was, held in place by the capsule, and nothing changes outwardly. This is why most silicone ruptures are silent.
Extracapsular rupture means gel has escaped beyond the capsule into surrounding breast tissue. This is less common but more consequential, since free silicone can cause inflammation, form firm nodules called silicone granulomas, and migrate—occasionally reaching the lymph nodes in the armpit. It requires more extensive surgery to address.
Saline rupture behaves entirely differently. The saline leaks out through the tear and is absorbed by the body, which handles salt water without difficulty. The implant deflates like a punctured balloon, visibly over hours to days. There is no health consequence whatsoever—the harm is cosmetic, and the empty shell is removed and usually replaced.
Modern silicone implants contain a cohesive gel that holds its shape rather than flowing freely. This cohesiveness is the reason contained rupture produces so little change and why gel does not disperse widely even when the shell fails. Earlier generations of implants, particularly those from the 1970s and 1980s, had thinner shells and more liquid gel, ruptured considerably more often, and leaked more readily. Much of the historical concern about silicone derives from these older devices, and current implants perform substantially better.
Rupture rates rise with implant age. Rupture is uncommon in the first few years and becomes progressively more frequent thereafter, with a meaningful proportion of silicone implants having ruptured by ten to fifteen years. Precise figures vary widely between studies, partly because of genuine differences between implant types and generations and partly because rates depend entirely on whether imaging was used to look for silent rupture or only symptomatic cases were counted.
Several factors influence rupture risk. Implant age is the dominant one. Older-generation implants with thinner shells ruptured more frequently. Trauma, including significant chest injury, can cause rupture, though everyday activity, exercise, and mammographic compression do not—a reassurance worth stating, since fear of causing rupture is a common reason women avoid mammography. Capsular contracture places increased pressure on the shell and is associated with higher rupture rates. Closed capsulotomy, an obsolete technique in which the capsule was broken by squeezing the breast forcefully, caused rupture frequently and is no longer performed.
Symptoms depend entirely on the fill type.
Saline rupture is unmistakable. The breast visibly deflates, becoming noticeably smaller and softer than the other side, usually over a day or two. There is no diagnostic uncertainty and no need for imaging.
Silicone rupture usually produces nothing. The term silent rupture captures this precisely: the woman feels normal, the breast looks normal, and examination is normal. Studies using MRI to screen asymptomatic women have consistently found ruptures that neither the woman nor her surgeon suspected.
Where silicone rupture does produce symptoms, these develop gradually and include a change in breast shape or size, new or increasing firmness, palpable lumps in the breast or armpit, visible rippling, pain, or asymmetry. These features are not specific to rupture and can also reflect capsular contracture, which frequently coexists.
Sudden pain and swelling after a significant chest injury warrants assessment, as does any acute change.
Redness, warmth, swelling, and fever point to infection rather than simple rupture and need prompt attention.
An important reassurance belongs here. There is no evidence that contained silicone from a ruptured implant causes systemic illness, autoimmune disease, or cancer. Large epidemiological studies have examined this extensively and have not demonstrated such links. This does not dismiss the systemic symptoms some women report and attribute to their implants—that is a separate and genuinely unresolved question addressed on our Breast Implants page—but it does mean that discovering a rupture is not cause for alarm about immediate harm.
Detection depends on imaging, and the choice of test matters.
MRI is the reference standard and is the most accurate means of diagnosing silicone rupture. It identifies the characteristic appearance of a collapsed shell floating within the surrounding gel, producing a series of curved parallel lines described as the linguine sign, which is essentially diagnostic. Other signs include the keyhole or noose sign, where gel has begun to track between folds of the shell, indicating early rupture. MRI also demonstrates extracapsular silicone clearly. Its drawbacks are cost, availability, and the need to lie still in the scanner, and it does not require contrast when performed specifically for implant assessment.
Ultrasound is widely accessible, inexpensive, involves no radiation, and performs reasonably well when carried out by someone experienced with implants. Intracapsular rupture produces a stepladder appearance, with the collapsed shell visible as parallel horizontal lines within the gel. Extracapsular silicone produces a characteristic bright, hazy appearance described as a snowstorm. Ultrasound is less sensitive than MRI, particularly for subtle or early rupture, and is more operator-dependent.
Mammography is poor at detecting contained rupture, since the implant appears as a uniform dense structure regardless of whether the shell inside it is intact. It does detect silicone that has escaped beyond the capsule, which may appear as dense nodules in surrounding tissue or in the armpit lymph nodes.
For saline implants, no imaging is required, since deflation is self-evident.
Whether asymptomatic women should be screened for silent rupture is genuinely contested, and practice differs internationally. Regulatory guidance in the United States has recommended periodic MRI or ultrasound surveillance for silicone implants beginning several years after placement and repeating at intervals. Practice in the United Kingdom and much of Europe has generally not recommended routine imaging in women without symptoms. The disagreement reflects real uncertainty: silent rupture is common, but it is not clear that finding it earlier changes outcomes, given that contained rupture causes no demonstrated harm and that surgery carries its own risks. It is reasonable to ask what approach applies locally and to make an informed choice.
Important to Know
Discovering a ruptured implant is not an emergency, and the decision about what to do can be made calmly. Care involves plastic and breast surgeons and breast radiologists.
For saline rupture, the position is simple. The saline has been absorbed harmlessly, there is no health consequence, and the only issue is appearance. Replacement, removal without replacement, or doing nothing at all are all legitimate choices, and the timing is entirely a matter of preference. Most women choose replacement because of the asymmetry.
For silicone rupture, removal is generally recommended, and the reasoning is worth understanding rather than accepting on authority. A contained rupture is not causing harm at the moment it is found. The argument for removal is that leaving it increases the chance that gel will eventually escape the capsule, which makes subsequent surgery more extensive, and that the problem will not improve on its own. The argument against urgency is that there is no demonstrated harm from contained silicone and no reason to rush. Both are true, which is why the usual advice is to plan removal rather than to arrange it immediately.
What is done at surgery varies with the circumstances. The implant is removed. The capsule may be left, partially removed, or completely removed—complete capsulectomy is generally performed where silicone has escaped beyond it, where the capsule is thickened or calcified, and where a woman specifically requests it, while routine complete removal of a normal capsule adds operative risk without demonstrated benefit. A new implant may be placed at the same time, or the woman may choose removal without replacement.
Extracapsular rupture requires more extensive surgery to remove free silicone and affected tissue, and complete clearance is not always achievable. Silicone that has reached the lymph nodes in the armpit is generally left alone, since removing nodes carries a risk of lymphoedema and the silicone itself is not causing harm.
Removal without replacement—explantation—is increasingly chosen and is entirely legitimate. Women should understand that the breast appearance afterwards differs from how it looked before implants were ever placed, since the tissue has been stretched and may have thinned over the years. Discussing realistic expectations and the option of a lift at the same operation is worthwhile beforehand.
Several practical points are worth knowing.
Mammography does not cause rupture. This fear is common and leads some women to avoid screening, which is a far greater risk to health than any theoretical risk from compression. Mammography with implants uses modified technique, and women should continue attending at the usual intervals, informing the service in advance.
Normal activity, exercise, and flying do not cause rupture.
Knowing your implant details is genuinely useful—manufacturer, type, size, and date of surgery. This information guides assessment and surgery and is often difficult to retrieve years later. Many countries now maintain implant registries for this reason.
Implants have a finite lifespan, and planning on the basis that further surgery will probably be needed at some point is realistic. This is worth understanding before a first operation rather than discovering it afterwards.
An important distinction deserves emphasis. Rupture and BIA-ALCL are entirely separate issues. Rupture is a mechanical failure of the shell. BIA-ALCL is a rare lymphoma arising in the capsule, associated with textured implants, which presents as persistent swelling of one breast developing years after surgery. Finding a rupture does not mean BIA-ALCL, and a ruptured implant is not more likely to cause it. The symptom that specifically warrants prompt assessment for BIA-ALCL is new unilateral swelling rather than the gradual changes associated with rupture.
Equally, rupture does not cause breast cancer and does not make cancer harder to detect beyond the limitation implants already impose on mammography. Any new breast lump, skin change, or nipple change should be assessed on its own merits rather than attributed to a known rupture.
For women with implants placed as part of reconstruction after breast cancer, rupture is managed similarly, though surveillance and decisions are coordinated with the oncology team, and previous radiotherapy affects both the likelihood of problems and the surgical options.
Care involves plastic surgery, breast surgery, and breast radiology. Imaging findings are interpreted alongside implant type and age, symptoms, and a woman’s own preferences about replacement, removal, or observation.
Patient education plays an important role. Understanding that silicone rupture is usually silent and requires imaging to detect, that saline rupture is obvious and harmless, that contained silicone has not been shown to cause systemic illness, that removal is advisable but rarely urgent, that mammography does not cause rupture, and that rupture is unrelated to BIA-ALCL all contribute to appropriate care and to decisions made calmly rather than under pressure.
Red flag symptoms include sudden deflation or marked change in the size or shape of one breast; new pain, firmness, or distortion developing over weeks; new lumps in the breast or armpit; redness, warmth, swelling, and fever, which suggest infection and require prompt assessment; persistent swelling of one breast developing years after implant surgery, which requires assessment for BIA-ALCL rather than being attributed to rupture; and any new breast lump, skin dimpling, or nipple change, which should be assessed on its own merits. These warrant medical evaluation, urgently where infection or persistent unilateral swelling is present.